Drug therapy and hereditary factors are two of the main causes of gingival
overgrowth (GO). Both of these forms of GO are associated with increased ex
tracellular matrix production by fibroblasts. Transforming growth factor be
ta (TGF-beta) is an important mediator of wound healing and tissue regenera
tion, which stimulates fibroblasts to produce extracellular matrix material
s. The aim of this immunohistochemical study was to determine whether there
is any altered expression of TGF-beta isoforms or its receptors in tissue
from patients with drug-induced GO (DIGO; n=10) and hereditary gingival fib
romatosis (n=10) when compared to non-overgrowth tissue (n=10). Compared to
control tissues, significantly more fibroblasts expressed TGF-beta1 in bot
h DIGO and hereditary gingival fibromatosis tissues (P<0.03). Cells express
ing TGF-<beta>2 were present at control levels in DIGO but were significant
ly reduced in hereditary gingival fibromatosis (P<0.02). By contrast, the n
umber of TGF-<beta>3-positive cells was the same in overgrowth tissues and
controls. However, because of differences in total fibroblast densities bet
ween groups, there was a proportional increase in TGF-beta3 as well as TGF-
beta1 expressing cells within both overgrowth populations (P<0.0001). Furth
ermore, representation of the TGF-<beta>2-positive phenotype was reduced in
hereditary gingival fibromatosis (P<0.01) but increased in DIGO (P<0.005)
compared to controls. Absorbance measurements of the positive cell populati
ons showed that the level of expression was significantly higher for TGF-be
ta1 in hereditary gingival fibromatosis (P<0.002) and significantly lower f
or TGF-<beta>3 in DIGO (P<0.03). No significant differences in the numbers
of TGF-<beta>RI- or RII-positive cells were detected between overgrowth tis
sues and controls. However, there were increases in the proportion of recep
tor-positive cells in the total cell population analysed in overgrowth tiss
ues (P<0.0001). These results indicate qualitative and quantitative differe
nces in TGF-<beta> isoform and receptor expression by fibroblasts in gingiv
al overgrowth that may contribute to disease pathogenesis.